/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Fresenius Medical Care (FMS) generated about $5.0 billion in revenue and $1.1 billion in net income (a 22.3% net margin) over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Fresenius Medical Care generated about $5.0 billion in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Yes, Fresenius Medical Care reported about $1.1 billion in net income over the trailing twelve months, a net profit margin of roughly 22.3%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
Fresenius Medical Care runs a gross margin of about 95.3%, an operating margin of about 45.4%, a net margin of about 22.3%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
SourceFinancial statements computed from the 10-K filed 25 Feb 2014, covering the period ending 31 Dec 2013, as reported to the SEC. Data last refreshed 17 Apr 2026. How this is calculated.